Back to Search Start Over

Findings from Duke Cancer Institute in Non-Small Cell Lung Cancer Reported (Timing of Palliative Care Consultation Impacts End of Life Care Outcomes In Metastatic Non-small Cell Lung Cancer).

Source :
Immunotherapy Weekly; 10/22/2024, p352-352, 1p
Publication Year :
2024

Abstract

A study conducted at Duke Cancer Institute in Durham, North Carolina, examined the impact of early specialist palliative care (PC) involvement on patients with metastatic non-small cell lung cancer (mNSCLC). The research found that early PC consultation was associated with improved quality of life, less aggressive end-of-life care, and longer survival. Despite the benefits of early PC integration, referrals to PC in mNSCLC still occur late or not at all. This real-world study highlights the importance of timely PC involvement in improving end-of-life care outcomes for patients with mNSCLC. [Extracted from the article]

Details

Language :
English
ISSN :
10908625
Database :
Complementary Index
Journal :
Immunotherapy Weekly
Publication Type :
Periodical
Accession number :
180340095